|4Jun 14, 6:56 PM ET

Agarwala Sandip 4

4 · Talaris Therapeutics, Inc. · Filed Jun 14, 2023

Insider Transaction Report

Form 4
Period: 2023-06-13
Agarwala Sandip
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-13+20,50020,500 total
    Exercise: $2.54Exp: 2033-06-13Common Stock (20,500 underlying)
Footnotes (1)
  • [F1]The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION